ATNC05, A Composition to Reduce Back Pain, A Proof-of-Concept, Randomized, Double-Blind - Placebo Controlled Study

Trial Profile

ATNC05, A Composition to Reduce Back Pain, A Proof-of-Concept, Randomized, Double-Blind - Placebo Controlled Study

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Jul 2013

At a glance

  • Drugs ALLOD 2 (Primary)
  • Indications Back pain; Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Sep 2012 Planned End Date changed from 1 Aug 2012 to 1 Aug 2014 as reported by ClinicalTrials.gov record.
    • 15 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top